Patients with persistent atrial fibrillation and metabolic comorbidities have an altered inflammatory state of atrial epicardial adipose tissue, which is linked to CT-attenuation

Heart, Artery and Coronary DiseasesFurther Publications

Association between inflammatory biomarkers, chronic stress, and pericoronary adipose tissue attenuation obtained with coronary CT

Eur Heart J Cardiovasc Imaging

Albertini T, Dörner M, Giannopoulos AA, von Känel R, Benz DC, Mikail N, de Wilde D, Voegel CD, Binz TM, Kaufmann PA, Gebhard C, Buechel RR, Pazhenkottil AP

doi: 10.1093/ehjci/jeaf217

Atrial Fibrillation

Atrial Fibrillation Progression in Patients with Device-Detected Subclinical Atrial Fibrillation: Insights from the ARTESiA Trial

Heart Rhythm

Boriani G, McIntyre WF, Ramasundarahettige C, Proietti M, Glotzer TV, Diemberger I, Nielsen JC, Essebag V, Granger CB, Sandhu RK, Benezet-Mazuecos J, Mabo P, Coutu B, Wong JA, Gold MR, Lopes RD, Healey JS, ARTESiA Investigators

doi: 10.1016/j.hrthm.2025.07.002

Atrial Fibrillation

Association of comorbidity patterns with outcomes and relation with the ABC pathway effectiveness in European patients with Atrial Fibrillation

Heart Rhythm

Romiti GF, Corica B, Mei DA, Vitolo M, Bucci T, Bisson A, Fauchier L, Boriani G, Proietti M, Lip GYH

doi: 10.1016/j.hrthm.2025.02.049

Atrial FibrillationHeart Failure

Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure: Insights from the NCDR Atrial Fibrillation Ablation Registry

Heart Rhythm

Yousuf O, Akar J, Tan Z, Alkalbani M, Tasneem H, Steinberg BA, Hsu JC, Atwater B, Yang E, Spertus J, Calkins H, Freeman JV

doi: 10.1016/j.hrthm.2025.06.048

Atrial Fibrillation

Clinical Impact of Switching From or Persisting With Rivaroxaban or Apixaban After a Bleeding Event: A Real-World Study in Patients With Nonvalvular Atrial Fibrillation

J Am Heart Assoc

Lip GYH, Cheng D, Jiang J, Gao C, Subash R, Vodicka E, Dubey A, Sharma PP, Vettumthara Unnikrishnan A, Mathivanan K, Deitelzweig S

doi: 10.1161/JAHA.125.044113

Cardiovascular Risk and Diseases

Cardio-kidney-metabolic complexity in patients with atrial fibrillation: an analysis from the prospective GLORIA-AF registry phase III

Cardiovasc Diabetol

Romiti GF, Mei DA, Corica B, Proietti M, Boriani G, Olshansky B, Chao TF, Huisman MV, Lip GYH, GLORIA-AF Investigators

doi: 10.1186/s12933-025-02950-y

Atrial FibrillationThrombosis and Stroke

Sex Differences and 2-Year Mortality in Patients With Atrial Fibrillation Diagnosed After Stroke and Known Atrial Fibrillation: A Register-Based Study in Sweden

J Am Heart Assoc

Al Khatib I, Viktorisson A, Abzhandadze T, Sunnerhagen KS

doi: 10.1161/JAHA.124.037608

Atrial Fibrillation

Integrated Care Management for Older Multimorbid Patients with Atrial Fibrillation: Rationale, Design and Baseline Characteristics for the Atrial Fibrillation Integrated Approach in Frail, Multimorbid and Polymedicated Older People (AFFIRMO) trial

Am Heart J

Proietti M, Lip GYH, Ainsworth J, Dan GA, Frost L, Graffigna G, Lucci D, Marin F, Potpara TS, Sanaullah A, Tokmakova M, Johnsen SP, Maggioni AP, AFFIRMO Study Investigators and Consortium

doi: 10.1016/j.ahj.2026.107356

Atrial Fibrillation

Left atrial appendage occlusion versus NOACs in patients with atrial fibrillation: Rationale and design of the CATALYST Trial

Am Heart J

Reddy VY, Hylek E, Camm AJ, Halperin JL, Diener HC, Thaler D, Schmidt B, Hara H, Huisman MV, Price MJ, Lakkireddy D, Gage R, Zhao H, Jensen TP, Quintana M, Windecker S

doi: 10.1016/j.ahj.2026.107367

Related content

Association between inflammatory biomarkers, chronic stress, and pericoronary adipose tissue attenuation obtained with coronary CT

Atrial Fibrillation Progression in Patients with Device-Detected Subclinical Atrial Fibrillation: Insights from the ARTESiA Trial

Association of comorbidity patterns with outcomes and relation with the ABC pathway effectiveness in European patients with Atrial Fibrillation

Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure: Insights from the NCDR Atrial Fibrillation Ablation Registry

Clinical Impact of Switching From or Persisting With Rivaroxaban or Apixaban After a Bleeding Event: A Real-World Study in Patients With Nonvalvular Atrial Fibrillation

Cardio-kidney-metabolic complexity in patients with atrial fibrillation: an analysis from the prospective GLORIA-AF registry phase III

Sex Differences and 2-Year Mortality in Patients With Atrial Fibrillation Diagnosed After Stroke and Known Atrial Fibrillation: A Register-Based Study in Sweden

Integrated Care Management for Older Multimorbid Patients with Atrial Fibrillation: Rationale, Design and Baseline Characteristics for the Atrial Fibrillation Integrated Approach in Frail, Multimorbid and Polymedicated Older People (AFFIRMO) trial

Left atrial appendage occlusion versus NOACs in patients with atrial fibrillation: Rationale and design of the CATALYST Trial